PROCEPT BioRobotics Corporation Common Stock (PRCT) is a publicly traded Healthcare sector company. As of September 21, 2026, PRCT trades at $19.31 with a market cap of $1.11B and a P/E ratio of -9.95. PRCT moved -0.87% today. Year to date, PRCT is -38.65%; over the trailing twelve months it is -49.25%. Its 52-week range spans $16.67 to $75.29. Analyst consensus is neutral with an average price target of $22.29. Rallies surfaces PRCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks PRCT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $19.31 |
| Market Cap | $1.11B |
| P/E Ratio | -9.95 |
| EPS | $-1.94 |
| Dividend Yield | 0.00% |
| 52-Week High | $75.29 |
| 52-Week Low | $16.67 |
| Volume | 723.89K |
| Avg Volume | 0 |
| Revenue (TTM) | $337.34M |
| Net Income | $-109.75M |
| Gross Margin | 64.22% |
10 analysts cover PRCT: 0 strong buy, 3 buy, 6 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $22.29.